Cargando…

Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy

SIMPLE SUMMARY: Induced pluripotent stem cells (iPSCs) that can be genetically engineered and differentiated into different types of immune cells, providing an unlimited resource for developing off-the-shelf cell therapies. Here, we present a comprehensive review that describes the current stages of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yang, Li, Miao, Zhou, Kuangyi, Brown, James, Tsao, Tasha, Cen, Xinjian, Husman, Tiffany, Bajpai, Aarushi, Dunn, Zachary Spencer, Yang, Lili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100203/ https://www.ncbi.nlm.nih.gov/pubmed/35565395 http://dx.doi.org/10.3390/cancers14092266

Ejemplares similares

Interleukin 15 in Cell-Based Cancer Immunotherapy
por: Zhou, Yang, et al.
Publicado: (2022)

Unlocking the potential of allogeneic Vδ2 T cells for ovarian cancer therapy through CD16 biomarker selection and CAR/IL-15 engineering
por: Lee, Derek, et al.
Publicado: (2023)

Development of Stem Cell-Derived Immune Cells for Off-the-Shelf Cancer Immunotherapies
por: Li, Yan-Ruide, et al.
Publicado: (2021)

Human γδ T Cell Subsets and Their Clinical Applications for Cancer Immunotherapy
por: Lee, Derek, et al.
Publicado: (2022)

Targeting Immunosuppressive Tumor-Associated Macrophages Using Innate T Cells for Enhanced Antitumor Reactivity
por: Li, Yan-Ruide, et al.
Publicado: (2022)

Minimally Invasive Preclinical Monitoring of the Peritoneal Cavity Tumor Microenvironment
por: Dunn, Zachary Spencer, et al.
Publicado: (2022)

Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention
por: Li, Yan-Ruide, et al.
Publicado: (2022)

Engineered human pluripotent stem cell-derived natural killer cells: the next frontier for cancer immunotherapy
por: Zhu, Huang, et al.
Publicado: (2019)

Engineering chimeric antigen receptor neutrophils from human pluripotent stem cells for targeted cancer immunotherapy
por: Chang, Yun, et al.
Publicado: (2022)

Induced Pluripotent Stem Cells: Challenges and Opportunities for Cancer Immunotherapy
por: Sachamitr, Patty, et al.
Publicado: (2014)

Current status of induced pluripotent stem cells in cardiac tissue regeneration and engineering
por: Liu, Zhiqiang, et al.
Publicado: (2013)

Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
por: Li, Yan-Ruide, et al.
Publicado: (2021)

Tissue Engineering Techniques for Induced Pluripotent Stem Cell Derived Three-Dimensional Cardiac Constructs
por: Salem, Tori, et al.
Publicado: (2022)

Biomaterial Engineering for Controlling Pluripotent Stem Cell Fate
por: Bertucci, Taylor B., et al.
Publicado: (2018)

Pluripotency of Induced Pluripotent Stem Cells
por: Feng, Chunjing, et al.
Publicado: (2013)

Induced Pluripotent Stem Cell as a New Source for Cancer Immunotherapy
por: Rami, Farzaneh, et al.
Publicado: (2016)

Site-Specific Genome Engineering in Human Pluripotent Stem Cells
por: Merkert, Sylvia, et al.
Publicado: (2016)

CRISPR Genome Engineering for Human Pluripotent Stem Cell Research
por: Chaterji, Somali, et al.
Publicado: (2017)

Design Principles for Pluripotent Stem Cell-Derived Organoid Engineering
por: Silva, Teresa P., et al.
Publicado: (2019)

Strategies for Genetically Engineering Hypoimmunogenic Universal Pluripotent Stem Cells
por: Zhao, Wei, et al.
Publicado: (2020)

Induced Pluripotent Stem Cells for Tissue-Engineered Skeletal Muscles
por: Zhao, Shudong, et al.
Publicado: (2023)

Engineered Platforms for Maturing Pluripotent Stem Cell–Derived Liver Cells for Disease Modeling
por: Yuan, Yang, et al.
Publicado: (2023)

Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies
por: Mazza, Roberta, et al.
Publicado: (2021)

Strategies for Cancer Immunotherapy Using Induced Pluripotency Stem Cells-Based Vaccines
por: Bernardes de Jesus, Bruno, et al.
Publicado: (2020)

Engineered Microvasculature in PDMS Networks Using Endothelial Cells Derived from Human Induced Pluripotent Stem Cells
por: Sivarapatna, Amogh, et al.
Publicado: (2017)

Off-the-shelf third-party HSC-engineered iNKT cells for ameliorating GvHD while preserving GvL effect in the treatment of blood cancers
por: Li, Yan-Ruide, et al.
Publicado: (2022)

Quantitative Proteomics and Metabolomics Reveal Biomarkers of Disease as Potential Immunotherapy Targets and Indicators of Therapeutic Efficacy
por: MacMullan, Melanie A., et al.
Publicado: (2019)

Generation of anti-GD2 CAR macrophages from human pluripotent stem cells for cancer immunotherapies
por: Zhang, Jue, et al.
Publicado: (2023)

Neural tissue engineering using embryonic and induced pluripotent stem cells
por: Willerth, Stephanie M
Publicado: (2011)

Micro-Engineered Models of Development Using Induced Pluripotent Stem Cells
por: Srivastava, Pallavi, et al.
Publicado: (2019)

‘Off the shelf’ immunotherapies: Generation and application of pluripotent stem cell‐derived immune cells
por: Wang, Chenxin, et al.
Publicado: (2023)

Genetically engineered T cells for cancer immunotherapy
por: Li, Dan, et al.
Publicado: (2019)

Telomere regulation in pluripotent stem cells
por: Huang, Yan, et al.
Publicado: (2014)

Pluripotency of induced pluripotent stem cells
por: Kang, Lan, et al.
Publicado: (2012)

Cartilage tissue engineering identifies abnormal human induced pluripotent stem cells
por: Yamashita, Akihiro, et al.
Publicado: (2013)

Targeted genome engineering in human induced pluripotent stem cells by penetrating TALENs
por: Ru, Renli, et al.
Publicado: (2013)

Engineering human pluripotent stem cells into a functional skeletal muscle tissue
por: Rao, Lingjun, et al.
Publicado: (2018)

Pluripotent Stem Cells for Retinal Tissue Engineering: Current Status and Future Prospects
por: Singh, Ratnesh, et al.
Publicado: (2018)

Pluripotency of Stem Cells from Human Exfoliated Deciduous Teeth for Tissue Engineering
por: Rosa, Vinicius, et al.
Publicado: (2016)

Leveraging Biomaterial Mechanics to Improve Pluripotent Stem Cell Applications for Tissue Engineering
por: Lenzini, Stephen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4d38e0740ufp7jcv7r5buv8jdt